Route 92 Medical, Inc.

Transaction overview

Reported completed

Exact closing date not established.

In a December 14, 2021 announcement, InnovaHealth Partners and Norwest Venture Partners were named as the new investors leading Route 92 Medical’s $56 million Series E equity round. A separate senior secured term loan from Runway Growth Capital provided up to $55 million. The round total is not InnovaHealth’s individual investment; its stake, contribution and exact closing day were not disclosed.

Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.